News on Incara Pharmaceuticals Corporation from BioPortfolio.com http://www.BioPortfolio.com Consolidated Incara Pharmaceuticals Corporation news from BioPortfolio.com Wed, 10 Feb 2010 03:17:46 GMT en Neurocrine Biosciences Announces the Appointment of William H. Rastetter to Its Board of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038915&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038915&THISHREF=http://c.moreover.com/click/here.pl%3fz2537835928%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038915&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038915&THISHREF=http://c.moreover.com/click/here.pl%3fz2537835928%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopipam in Lesch-Nyhan Diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033281&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033281&THISHREF=http://c.moreover.com/click/here.pl%3fz2535096978%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033281&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033281&THISHREF=http://c.moreover.com/click/here.pl%3fz2535096978%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Westaim announces completion of amalgamation with NUCRYST Pharmaceuticals Corp.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032746&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032746&THISHREF=http://c.moreover.com/click/here.pl%3fz2534797554%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032746&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032746&THISHREF=http://c.moreover.com/click/here.pl%3fz2534797554%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTickerTech.com: King Pharmaceuticals Appoints Two New Members to Its Board of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038424&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038424&THISHREF=http://c.moreover.com/click/here.pl%3fz2537606747%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038424&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038424&THISHREF=http://c.moreover.com/click/here.pl%3fz2537606747%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: King Pharmaceuticals Appoints Two New Members to Its Board of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038286&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038286&THISHREF=http://c.moreover.com/click/here.pl%3fz2537556358%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038286&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038286&THISHREF=http://c.moreover.com/click/here.pl%3fz2537556358%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarket Wire: Tekmira Pharmaceuticals Announces 2010 Milestoneshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038032&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038032&THISHREF=http://c.moreover.com/click/here.pl%3fz2537446504%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038032&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038032&THISHREF=http://c.moreover.com/click/here.pl%3fz2537446504%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBoston Globe: Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones And The Initiation Of A Clinical Trial Of Ecopiphttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037773&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037773&THISHREF=http://c.moreover.com/click/here.pl%3fz2537281352%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037773&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037773&THISHREF=http://c.moreover.com/click/here.pl%3fz2537281352%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopiphttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036888&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036888&THISHREF=http://c.moreover.com/click/here.pl%3fz2536814720%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036888&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036888&THISHREF=http://c.moreover.com/click/here.pl%3fz2536814720%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Tekmira Pharmaceuticals Announces 2010 Milestones - Zibb.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035473&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035473&THISHREF=http://c.moreover.com/click/here.pl%3fz2536254892%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035473&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035473&THISHREF=http://c.moreover.com/click/here.pl%3fz2536254892%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: The Westaim Corporation: Westaim Announces Completion Of Amalgamation With Nucryst Pharmaceuticals Corp.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035110&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035110&THISHREF=http://c.moreover.com/click/here.pl%3fz2536118829%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035110&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035110&THISHREF=http://c.moreover.com/click/here.pl%3fz2536118829%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: The Westaim Corporation: Westaim Announces Completion Of Amalgamation With Nucryst Pharmaceuticals Corp.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035105&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035105&THISHREF=http://c.moreover.com/click/here.pl%3fz2536115915%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035105&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035105&THISHREF=http://c.moreover.com/click/here.pl%3fz2536115915%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: FDA accepts Psyadon Pharmaceuticals' ecopipam IND for treatment of LNDhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033795&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033795&THISHREF=http://c.moreover.com/click/here.pl%3fz2535407077%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033795&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033795&THISHREF=http://c.moreover.com/click/here.pl%3fz2535407077%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopipam in Lesch-Nyhan Diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033488&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033488&THISHREF=http://c.moreover.com/click/here.pl%3fz2535235492%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033488&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033488&THISHREF=http://c.moreover.com/click/here.pl%3fz2535235492%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCentre Daily Times: Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopiphttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033306&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033306&THISHREF=http://c.moreover.com/click/here.pl%3fz2535116517%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033306&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033306&THISHREF=http://c.moreover.com/click/here.pl%3fz2535116517%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopiphttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033298&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033298&THISHREF=http://c.moreover.com/click/here.pl%3fz2535113523%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033298&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Incara%20Pharmaceuticals%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033298&THISHREF=http://c.moreover.com/click/here.pl%3fz2535113523%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTMC Net: